The partnership combines Kent’s tissue assessment devices, SnapshotNIR and SnapshotGLO with Marathon Medical’s more than 20 years of experience serving the VA.

This partnership continues to advance our mission of improving outcomes for patients by making Kent Imaging’s technology more accessible to Veterans and the broader government healthcare community.”

— Pierre Lemire, CEO

CALGARY, AB – ALBERTA, CANADA, August 26, 2026 /EINPresswire.com/ — Kent Imaging Inc., a leader in near-infrared tissue oxygenation and bacterial autofluorescence imaging, has announced a new partnership with Marathon Medical Corporation, a Service-Disabled Veteran-Owned Small Business (SDVOSB) specializing in federal healthcare distribution. Together, the organizations will expand access to Kent Imaging’s advanced wound imaging technologies across U.S. Department of Veterans Affairs (VA) healthcare facilities, helping clinicians identify patients at risk for wound complications earlier and support better outcomes for America’s Veterans.

The partnership combines Kent Imaging’s point-of-care tissue assessment devices, SnapshotNIR and SnapshotGLO, and any future product developments, with Marathon Medical’s more than 20 years of experience serving the VA, Department of Defense, and other federal healthcare agencies. Founded by Vietnam Veteran John St. Leger, Marathon Medical has built its business around supporting the federal healthcare system that serves those who have served the country.

Chronic wounds and lower extremity complications remain a significant health concern within the Veteran population, particularly among patients living with diabetes and peripheral arterial disease (PAD). By providing clinicians with objective information about tissue oxygenation and bacterial burden at the bedside, Kent Imaging’s solutions help support earlier clinical decision-making to improve healing outcomes and reduce preventable amputations.

“This partnership continues to advance our mission of improving outcomes for patients by making Kent Imaging’s technology more accessible to Veterans and the broader government healthcare community,” said Pierre Lemire, CEO of Kent Imaging. “We are proud to work with Marathon Medical to bring innovative imaging solutions to the clinicians who care for patients in need.”

“Echoing that commitment, this partnership gives us an opportunity to put that mission into action by expanding access to advanced wound imaging where it can make a meaningful difference in patient care,” adds Chris Tiemann, Vice President of Sales, Kent Imaging.

As a Service-Disabled Veteran-Owned Small Business, Marathon Medical is dedicated to delivering high-quality medical products and professional, personalized service throughout the federal healthcare system. The company works closely with VA hospitals, military treatment facilities, and other government agencies to ensure providers have timely access to innovative medical technologies.

“At Marathon Medical, our mission has always been to serve those who served. We are pleased to have Kent Imaging’s Snapshot suite as part of that mission,” said Jon Landis, Chief Commercialization Officer, Marathon Medical.

The partnership underscores both organizations’ commitment to advancing Veteran Healthcare through innovation while strengthening collaboration between medical technology companies and veteran-owned businesses dedicated to serving the federal healthcare community.

About Kent Imaging
Based in Calgary, Alberta, Canada, Kent Imaging is a leading innovator in advanced imaging technology. The company designs, manufactures, and markets medical devices that support real-time decision-making in wound care, vascular, and surgical specialties. Through patented technologies, Kent continues to deliver groundbreaking solutions that support healthcare systems around the world.
The Snapshot product suite now includes two powerful imaging devices: SnapshotNIR, a near-infrared tissue oxygenation imaging device initially cleared by the FDA and Health Canada in 2017 and CE-marked in 2025; and SnapshotGLO, a bacterial autofluorescence imaging device that received FDA 510(k) clearance in 2025. SnapshotNIR is supported by clinical evidence demonstrating its role in enhancing clinical decision-making, while SnapshotGLO provides real-time insight into wound bioburden presence and distribution. Together, the Snapshot product family strengthens clinicians’ ability to detect, direct, and protect—promoting treatment consistency, supporting improved workflow, and contributing to better patient care worldwide.

SnapshotGLO® is a registered trademark of Kent Imaging Inc.
SnapshotNIR® is a registered trademark of Kent Imaging Inc.

About Marathon Medical
Founded in 2002, Marathon Medical Corporation is a Service-Disabled Veteran-Owned Small Business (SDVOSB) headquartered in Aurora, Colorado. The company specializes in supplying medical products to the U.S. Department of Veterans Affairs, Department of Defense, and other federal healthcare agencies, with a mission to provide excellence to the healthcare supply chain through professional, personal service.

Leah Pavlick
Kent Imaging Inc.
leah@kentimaging.com
Visit us on social media:
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Media gallery

About The Author